DHG Pharmaceutical JSC (HOSE:DHG)

Vietnam flag Vietnam · Delayed Price · Currency is VND
99,700
+200 (0.20%)
At close: Apr 28, 2026
2.47%
Market Cap 13.04T
Revenue (ttm) 5.27T
Net Income (ttm) 872.74B
Shares Out 130.75M
EPS (ttm) 6,675.06
PE Ratio 14.94
Forward PE 12.87
Dividend 10,000.00 (10.05%)
Ex-Dividend Date n/a
Volume 18,028
Average Volume 14,111
Open 99,500
Previous Close 99,500
Day's Range 99,500 - 100,000
52-Week Range 96,600 - 110,700
Beta 0.39
RSI 42.89
Earnings Date Apr 17, 2026

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, dermatology, and beauty care products. It also manufactures and trades in health food, dietary and consumer health supplements, and pharmaceuticals cosmetic products. It also exports its products. DHG Pharmaceutical... [Read more]

Industry Pharmaceutical Preparations
Founded 1974
Employees 2,819
Stock Exchange Ho Chi Minh Stock Exchange
Ticker Symbol DHG
Full Company Profile

Financial Performance

In 2025, DHG Pharmaceutical JSC's revenue was 5.27 trillion, an increase of 7.82% compared to the previous year's 4.88 trillion. Earnings were 824.78 billion, an increase of 9.45%.

Financial Statements

News

There is no news available yet.